Kedudukan dalam Saham
#26169
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
Perubahan (1 tahun)
-18.85%
Perdagangan Molecure S.A. (MOC)
Harga MOC dengan permodalan pasaran b
Modal pasaran bagi Molecure S.A.(MOC)
Modal Pasaran: $42.88M
Sehingga August 2026, Molecure S.A. mempunyai modal pasaran sebanyak $42.88M. Ini menjadikan Molecure S.A. syarikat ke-26169th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Molecure S.A. dari 2018 hingga 2026
MOC berbanding dengan 5 teratas yang paling popular stocks
| Harga MOC |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.253T
|
+12,251,610.49%
|
|
|
|
|
$4.658T
|
+10,865,049.72%
|
|
|
|
|
$4.101T
|
+9,564,771.40%
|
|
|
|
|
$3.591T
|
+8,375,262.06%
|
|
|
|
|
$2.831T
|
+6,603,150.24%
|
